TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 1 | 0 | 0 | -16 | -4 | 66 | 12 |
| P | %wins | 100 | 50 | 50 | 50 | 50 | 50 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/21/18 14:03 | 12/20/18 | CHMA | Chiasma, Inc | DE | Health | Drug | Pharmaceutical Preparations | Fitzpatrick Mark J. | MA | DO | P,CEO | P | 24 | 2.50 | 0 | 10 | New | 10 | D | ||||||||||||||
8/20/14 09:36 | 8/19/14 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fitzpatrick Mark J. | MA | O | CFO | P | 35 | 30.64 | 33 | 1 | 14 | 10 | D | 113 | -65 | -51 | 1 | 5 | -14 | -3 | 3 | 1 | 1 | 11 | -35 | -14 | -41 |
3/26/12 09:27 | 3/23/12 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fitzpatrick Mark J. | MA | O | CFO | P | 7 | 14.15 | 1 | 1 | New | 1 | D | -18 | -3 | -15 | -15 | -20 | -12 | -5 | 0 | -1 | -11 | 4 | 6 | 173 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |